Generic Erlotinib Cancer Medicine


 What is Erlotinib

#Erlotinib is a targeted therapy. #Erlotinib is classified as a epidermal growth factor receptor (EGFR) inhibitor - protein-tyrosine kinase inhibitor. Erlotinib comes in form of tablets and available under 100 mg and 150 mg strength under various brands from indian and multinational manufacturers.

Uses of Erlotinib

Erlotinib is used for:-

  • Treating certain types of advanced or metastatic #lungcancer.
  • Treating certain types of #pancreaticcancer in combination with another medicine (gemcitabine).

Most Common Side Effects of Erlotinib

  • Diarrhea
  • Weakness
  • Rash
  • Cough
  • Shortness of breath
  • Loss of appetite (not wanting to eat)
  • Fatigue (feeling very tired)
  • Nausea

If any of these effects persist or worsen, notify your doctor or pharmacist promptly.

This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.


Important Safety Information

  • Before taking erlotinib, tell your doctor or pharmacist if you are allergic to it; or if you have any other allergies. This product may contain inactive ingredients, which can cause allergic reactions or other problems. Talk to your pharmacist for more details.
  • Before using this medication, tell your doctor or pharmacist your medical history, especially of: liver disease, kidney problems, stomach/intestinal disease (such as ulcers, diverticulosis).
  • Use caution with sharp objects like safety razors or nail cutters and avoid activities such as contact sports to lower the chance of getting cut, bruised or injured.
  • This medicine may increase your risk of stomach bleeding. Limit alcoholic beverages.
  • Sunlight may worsen any skin reactions that may occur while you are taking this drug. Avoid prolonged sun exposure, tanning booths, and sunlamps. Use a sunscreen and wear protective clothing when outdoors.
  • This drug is not recommended for use during pregnancy. It may cause harm to an unborn baby or miscarriage. Women of childbearing age should use reliable form(s) of birth control during treatment and for at least 2 weeks following the end of treatment with this drug. Consult your doctor for more details.
  • It is not known whether this drug passes into breast milk. Because of the potential risk to the infant, breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.

 Indian Brand Available for Erlotinib :-


#Erlocip100mg Erlotinib Cipla
http://www.oddwayinternational.com/erlocip-100-mg-erlotinib-cipla
Cipla Erlotinib 100 mg

Cipla Erlotinib Tablets Details:

Brand Name : Erlocip
Active Ingredients : Erlotinib Hydrochloride
Manufactured by: Cipla Limited.
Strength: 100 mg
Form: Tablets
Packing: Pack of 30 Tablets


Erlotinib Tablets #Erlocip150
Erlocip 150 mg Erlotinib
Cipla Erlotinib Tablets Specification:

Brand Name : Erlocip
Active Ingredients : Erlotinib Hydrochloride
Manufactured by: Cipla Limited.
Strength: 150 mg
Form: Tablets
Packing: Pack of 30 Tablets

Location: China

Comments

Post a Comment

Popular posts from this blog

Image
Breast Cancer Awareness Month - October October is #BreastCancer Awareness Month when worldwide annual campaigns are carried out to highlight the importance of breast cancer awareness, education and research.  Breast cancer is a malignant tumor that starts in the cells of the breast and can gradually spread to other parts of the body. With the help of regular mammography screening, breast cancers can be found at an early stage. The most common sign of breast cancer is a lump formation in the breast. Breast cancer is the most common cancer among American women, except for skin cancers. About 1 in 8 women in the U.S. may develop invasive breast cancer during their lifetime. Breast cancers can start from different parts of the breast, with the most common ones beginning in the ducts that carry milk to the nipple (ductal cancers). Some start in the glands that make breast milk (lobular cancers). It can spread through the lymph system, which includes lymph nodes, lymph ...
Read more
Image
Top 7 Causes of KIDNEY CANCER : Who is at Risk ? Of all types of #KidneyCancer, which can develop in adult, renal cell carcinoma (RCC) is the most common. It accounts for about 90 percent of diagnosed kidney cancer. Although the exact cause is unknown for RCC, there are certain risk factors that can increase the chance of developing kidney cancer. Keep reading to learn about the seven major risk factors. YOUR AGE People have a greater chance of developing RCC, as they get older. YOUR GENDER Males have double the chance of having RCC compared to females. YOUR GENES Genetics may play a role in the development of RCC. Several rare hereditary disorders, such as von Hippel-Lindau disease and hereditary (or familial) papillary RCC, put you at greater risk of developing RCC. Von Hippel-Lindau leads tumor in more than one part of your body. Hereditary papillary RCC is associated with changes in certain genes. YOUR FAMILY HISTORY Even if you do not have any of the inherited ...
Read more
Image
SYMPTOMS OF PROSTATE CANCER The word "prostate" comes from Medieval Latin prostate and Medieval French prostate. The ancient Greek word prostates means " one standing in front ", from proistanai meaning " set before ". The prostate is so called because of its position - it is at the base of the bladder.                                                       ABOUT PROSTATE CANCER The prostate is a gland in the male reproductive system . It lies just below the bladder (the organ that collects and empties urine) and in front of the rectum (the lower part of the intestine). It is about the size of a walnut and surrounds part of the urethra (the tube that empties urine from the bladder) . The prostate gland makes fluid that is part of the semen.                  Signs and Symptoms of Prostate Cancer ...
Read more